"On March 24,2016, Manzo issued a second press release, also drafted by Barton, restating the same misleading information contained in the February 16 press release. 89. At the same time that Manzo Pharmaceuticals issued the above misleading press releases, Barton, Goode and Peachtree converted their Manzo Pharmaceuticals debt into unregistered Manzo Pharmaceuticals stock and sold them to the public. All told, between June2014 and March 2016, Barton and Goode generated over $493,000 by selling 981 million shares of Manzo Pharmaceuticals stock"